Literature DB >> 7370530

Postpartum haemolytic-uraemic syndrome successfully treated with antithrombin III.

P Brandt, J Jespersen, G Gregersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370530      PMCID: PMC1600470          DOI: 10.1136/bmj.280.6212.449

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Postpartum hemolytic uremic syndrome.

Authors:  R G Strauss; R W Alexander
Journal:  Obstet Gynecol       Date:  1976-02       Impact factor: 7.661

2.  Antithrombin 3. Protection against death after injection of thromboplastin.

Authors:  L T Mann; J C Jensenius; M Simonsen; U Abildgaard
Journal:  Science       Date:  1969-10-24       Impact factor: 47.728

3.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.

Authors:  D Collen; J Schetz; F de Cock; E Holmer; M Verstraete
Journal:  Eur J Clin Invest       Date:  1977-02       Impact factor: 4.686

4.  Heparin-induced decrease in circulating antithrombin-III.

Authors:  E Marciniak; J P Gockerman
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

  4 in total
  3 in total

Review 1.  Hemolysis, elevated liver enzymes, and low platelets in pregnancy (HELLP syndrome). A case report and literature review.

Authors:  B Schorr-Lesnick; B Dworkin; W S Rosenthal
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

2.  Deficiency of antithrombin III in children with hemolytic-uremic syndrome.

Authors:  B Roth; T von Lilien; B Busch; A Gillor; M Bulla
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

3.  Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.

Authors:  Megha Gupta; Shravya Govindappagari; Richard M Burwick
Journal:  Obstet Gynecol       Date:  2020-01       Impact factor: 7.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.